Keros Therapeutics, Inc. [KROS]

Source: 

Company Overview

Keros Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta, or TGF-  , family of proteins. We are a leader in understanding the role of the TGF-   family of proteins, which are master regulators of the growth, repair and maintenance of a number of tissues, including blood, bone, skeletal muscle, adipose and heart tissue.